InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,761.09
(
0.34%
)
Post# of 251938
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

frontiers

Send PM Follow Ignore
Followers 21
Posts 590
Boards Moderated 0
Alias Born 11/12/2009

frontiers

Re: DewDiligence post# 183697

Monday, 11/10/2014 12:35:18 PM

Monday, November 10, 2014 12:35:18 PM

Post# of 251938

If ACH-3422 is an “enhanced Sovaldi” (as you claim), how can ACH-3422 be a good fit with a portfolio that already includes Harvoni as well as Sovaldi?



Yes, I believe ACH 3422 will every bit as good as sovaldi in this trial and in future trials ... and I agree with you ... I have never seriously thought GILD to be an ACHN acquirer ... for one thing, they could run afoul of anti-trust laws ... I see a better fit of ACHN with BMY and Roche in particular ...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up